Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000144346 | SCV001711964 | benign | Angelman syndrome | 2021-03-26 | reviewed by expert panel | curation | The allele frequency of the c.2064+9T>C variant in UBE3A is 0.4% in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions. Splice prediction analysis, using multiple computational tools does not suggest an impact to splicing (BP4). In summary, the c.2064+9T>C variant in UBE3A is classified as benign based on the ACMG/AMP criteria (BA1, BP4). |
Gene |
RCV000082346 | SCV000169715 | benign | not specified | 2016-06-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000082346 | SCV000195359 | benign | not specified | 2017-06-22 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000082346 | SCV000333389 | benign | not specified | 2015-07-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000144346 | SCV000559149 | benign | Angelman syndrome | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000858258 | SCV001146578 | benign | not provided | 2018-12-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000858258 | SCV004033361 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | UBE3A: BS1, BS2 |
Breakthrough Genomics, |
RCV000858258 | SCV005297380 | benign | not provided | criteria provided, single submitter | not provided | ||
Baylor Genetics | RCV000144346 | SCV000188523 | uncertain significance | Angelman syndrome | 2014-02-14 | no assertion criteria provided | clinical testing | possible diagnosis of Angelman syndrome |
Genome Diagnostics Laboratory, |
RCV000082346 | SCV001931594 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000082346 | SCV001953711 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003925078 | SCV004743586 | benign | UBE3A-related disorder | 2019-05-09 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |